Rani Therapeutics Holdings (RANI) Current Leases (2022 - 2026)

Rani Therapeutics Holdings has reported Current Leases for 5 years, with the latest figure at $1.3 million in Q2 2026.

• On a quarterly basis, Current Leases rose 11.77% year-over-year to $1.3 million in Q2 2026; TTM through Jun 2026 was $1.3 million, a 11.77% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 8.7% from the prior year.
• Current Leases was $1.3 million for Q2 2026 at Rani Therapeutics Holdings, down from $1.5 million in the prior quarter.
• The five-year high for Current Leases was $1.6 million in Q4 2025, with the low at $650000.0 in Q1 2022.
• Average Current Leases over 5 years is $1.1 million, with a median of $1.1 million recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Current Leases decreased 28.63% in 2023, then surged 103.2% in 2024.
• Over 5 years, Current Leases stood at $1.0 million in 2022, then fell by 28.63% to $718000.0 in 2023, then soared by 103.2% to $1.5 million in 2024, then climbed by 8.7% to $1.6 million in 2025, then retreated by 16.2% to $1.3 million in 2026.
• The last three Current Leases figures came in at $1.3 million (Q2 2026), $1.5 million (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.